Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Chemoradiotherapy”

696 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 696 results

Testing effectiveness (Phase 2)Study completedNCT01797900
What this trial is testing

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Neoplasms
Chinese Academy of Medical Sciences 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621707
What this trial is testing

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Who this might be right for
Esophageal Squamous Cell CarcinomasConcurrent ChemoradiotherapyImmunotherapy+1 more
Shanghai Chest Hospital 50
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Testing effectiveness (Phase 2)Study completedNCT04541355
What this trial is testing

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

Who this might be right for
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Head and Neck Squamous Cell Carcinoma+26 more
Hyunseok Kang, MD
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Testing effectiveness (Phase 2)Study completedNCT05944809
What this trial is testing

The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

Who this might be right for
Esophageal CancerIntensity-modulated Radiation TherapyConcurrent Chemoradiotherapy+1 more
JIANYANG WANG 32
Testing effectiveness (Phase 2)Study completedNCT00418535
What this trial is testing

Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell
Samsung Medical Center
Not applicableStudy completedNCT02068950
What this trial is testing

Progressive Resistance Training Program in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Herlev Hospital 12
Early research (Phase 1)Study completedNCT00950417
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Who this might be right for
Advanced Esophageal
Biotech Pharmaceutical Co., Ltd. 11
Not applicableStudy completedNCT03880396
What this trial is testing

Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Assiut University 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06419673
What this trial is testing

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT07361497
What this trial is testing

Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 850
Not applicableLooking for participantsNCT06277388
What this trial is testing

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.

Who this might be right for
Non-small Cell Lung CancerCardiac Toxicity
Sun Yat-sen University 237
Testing effectiveness (Phase 2)UnknownNCT04814069
What this trial is testing

Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Study

Who this might be right for
Head and Neck CancerRadiationPD-1
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 38
Large-scale testing (Phase 3)UnknownNCT04138992
What this trial is testing

A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

Who this might be right for
Disease Free Survival
Air Force Military Medical University, China 150
Not applicableStudy completedNCT01766349
What this trial is testing

Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients

Who this might be right for
Esophageal Cancer
Far Eastern Memorial Hospital 100
Not applicableUnknownNCT03567135
What this trial is testing

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Who this might be right for
Glioblastoma
Fuzhou General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00004089
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05177497
What this trial is testing

SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Shanghai Chest Hospital 19
Testing effectiveness (Phase 2)UnknownNCT05483543
What this trial is testing

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 44
Load More Results
16